XL
Xiao-Yu Lai
Hematopoietic Stem Cell TransplantationGraft vs Host DiseaseLeukemia, Myeloid, Acuteallogeneic hematopoietic stem cell transplantationastro-ph.HEHematologic NeoplasmsMyelodysplastic Syndromesastro-ph.SRnucl-thacute myeloid leukemia
On Valency
published · living versionsW_dpfbqr6h·v1 · currentpublished
Extended 2.25/8.60 GHz Observations of the Magnetar Swift J1818.0-1607
with Zhi-Peng Huang, Zhen Yan, Zhi-Qiang Shen, Hao Tong +9
1 version
Preprints & journals
118 papers in the corpus · 2004–2026Peritransplant molecular MRD monitoring by targeted NGS in patients with FLT3-ITD-mutated acute myeloid leukemia.42263741 · Hu, Xiaoxia, Zhao, Yeqian, Jiang, Chuanhe et al.2026 · 1 citationBlood advances. 2026;10(16):5607-5619
Low-dose ruxolitinib for graft-versus-host disease prevention in haploidentical haematopoietic stem-cell transplantation: a multicentre, open-label, randomised, controlled, phase 3 trial.42532067 · Wu, Hengwei, Shi, Wenming, Shi, Zhuoyue et al.2026 · 0 citationsThe Lancet. Haematology. 2026;13(8):e533-e544
Systemic Treatment With the ROCK2 Inhibitor Belumosudil in Ocular Chronic Graft-Versus-Host Disease.42521137 · Wu, Yibo, Ye, Bei, Lai, Xiaoyu et al.2026 · 0 citationsAmerican journal of ophthalmology. 2026;292:51-57
Low-dose chidamide maintenance therapy following allogeneic hematopoietic cell transplantation in T-cell acute lymphoblastic leukemia or lymphomas: a phase II, open-label, multicenter, single-arm trial.42518787 · Zhao, Yanmin, Chen, Weihao, Yu, Yi et al.2026 · 0 citationsThe Lancet regional health. Western Pacific. 2026;72:101916
Salvage Therapy With Inotuzumab Ozogamicin in Relapsed/Refractory B-ALL After CAR-T Therapy and HSCT: A Case Series.42387626 · Li, Honghu, Yang, Luxin, Liu, Lizhen et al.2026 · 0 citationsCancer reports (Hoboken, N.J.). 2026;9(7):e70601
Peri-transplant TP53 molecular MRD as a prognostic biomarker of relapse in TP53-mutated AML/MDS undergoing allogeneic HCT.42362536 · Zhao, Yeqian, Cao, Weijie, Shi, Jimin et al.2026 · 2 citationsBlood cancer journal. 2026;16(1)
Integration of venetoclax into a fludarabine and melphalan conditioning regimen in patients aged 50 years and older with acute myeloid leukemia and myelodysplastic syndrome: Results from a phase 2 clinical trial.42159161 · Lai, Xiaoyu, Zhu, Panpan, Yang, Luxin et al.2026 · 0 citationsCancer. 2026;132(11):e70467
Pre-Transplant MRD Negativity and Age Under 40 Predict Superior Long-Term Survival in Relapsed/Refractory B-ALL After CAR-T Therapy Bridging to Haploidentical HSCT: A Multicenter Retrospective Study With 6-Year Follow-Up.42130055 · Zhao, Houli, Lin, Zhouning, Zheng, Haiqiong et al.2026 · 0 citationsAmerican journal of hematology. 2026;101(8):1866-1877
The safety and efficacy of belumosudil and ruxolitinib combination in ruxolitinib refractory cGVHD.41876848 · Wu, Yibo, Liu, Lizhen, Chen, Yi et al.2026 · 1 citationBone marrow transplantation. 2026;61(5):625-627
Validation of risk stratification and novel prognostic biomarkers in asian adult HSCT recipients with TA-TMA: A multicenter real-world study.41514049 · Wu, Yibo, Yuan, Xiaolin, Chen, Lieguang et al.2026 · 1 citationBone marrow transplantation. 2026;61(4):408-416
Prognostic impact of clinico-genetic characteristics and donor types in NPM1-mutated AML undergoing allogeneic hematopoietic stem cell transplantation.41679976 · Yuan, Xiaolin, Wu, Yibo, Yang, Tingting et al.2026 · 0 citationsCell transplantation. 2026;35:9636897251414205
Pre-transplant Clostridioides difficile infection predicts subsequent gastrointestinal GVHD and non-relapse mortality after allogeneic hematopoietic stem cell transplantation.42287211 · Wang, Wenyi, Wu, Yibo, Chen, Yunbo et al.2026 · 0 citationsCell transplantation. 2026;35:9636897261461629
Donor leukocyte telomere length emerges as a prognostic factor for transplantation outcomes.41789132 · Wu, Hengwei, Yu, Jing, Cao, Yang et al.2026 · 0 citationsInnovation (Cambridge (Mass.)). 2026;7(3):101147
Impact of clinical characteristics and genetic profiles on outcomes of allogeneic stem cell transplantation with sorafenib maintenance in FLT3-ITD acute myeloid leukemia patients: A multi-center, retrospective study.40979666 · Zhao, Yeqian, Jiang, Chuanhe, Luo, Yi et al.2025 · 3 citationsChinese journal of cancer research = Chung-kuo yen cheng yen chiu. 2025;37(4):521-533
Machine learning-based prediction of G-CSF-induced hematopoietic stem cell mobilization outcomes in healthy volunteers.40615536 · Shi, Ce, Zeng, Xiangjun, Ge, Jimei et al.2025 · 3 citationsBone marrow transplantation. 2025;60(10):1316-1324
KRAS mutation status critically determines the clinical outcome of patients with KMT2A-rearranged acute myeloid leukemia.40530668 · Wu, Yibo, Yuan, Xiaolin, Lai, Xiaoyu et al.2025 · 4 citationsCancer. 2025;131(13):e35941
Salvage treatment of steroid-refractory acute GVHD with the off-the-shelf product of human umbilical cord mesenchymal stromal cells: a multicenter, open label, phase Ib/IIa trial.40597363 · Zhao, Yanmin, Luo, Yi, Shi, Jimin et al.2025 · 4 citationsStem cell research & therapy. 2025;16(1):345
Higher risk of platelet engraftment failure and chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation following chimeric antigen receptor T-cell therapy compared to chemotherapy: A propensity score-matched analysis.40464130 · Yang, Luxin, Lai, Xiaoyu, Liu, Lizhen et al.2025 · 2 citationsBritish journal of haematology. 2025;207(1):162-170
Superior outcomes of haploidentical hematopoietic cell transplantation over chemotherapy in AML patients 55 years or older.40159557 · Li, Lin, Zhu, Lixia, Xiong, Mengqi et al.2025 · 1 citationBone marrow transplantation. 2025;60(6):773-778
A first-in-class JAK/ROCK inhibitor, rovadicitinib, for glucocorticoid-refractory or -dependent chronic GVHD.40009501 · Zhao, Yanmin M, Luo, Yi, Shi, Jimin M et al.2025 · 19 citationsBlood. 2025;145(24):2857-2872
Adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation and tyrosine kinase inhibitors: development and validation of a clinical prediction model based on cytogenetics, IKZF1 deletions and minimal residual disease.39843812 · Zheng, Jing, Zhou, Yuping, Zhao, Yanmin et al.2025 · 0 citationsAnnals of hematology. 2025;104(3):1867-1876
Better pre-transplant treatment options for TP53-mutated MDS: cytoreductive or non-cytoreductive therapy?39627346 · Jiang, Bingqian, Yang, Tingting, Zhao, Yanmin et al.2025 · 3 citationsBone marrow transplantation. 2025;60(3):326-334
Validation and refinement of the 2022 European LeukaemiaNet genetic risk classification of acute myeloid leukaemia patients receiving allogeneic haematopoietic cell transplantation.39468195 · Chen, Weihao, Chen, Lieguang, Cao, Yang et al.2026 · 2 citationsLeukemia. 2024;38(12):2712-2716
Epstein-Barr virus positive post-transplant lymphoproliferative disorder with significantly decreased T-cell chimerism early after transplantation: A case report.39494132 · Guo, Qing-Na, Liu, Hai-Sheng, Li, Lin et al.2024 · 0 citationsWorld journal of radiology. 2024;16(10):600-607
Impact of additional cytogenetic aberrations at diagnosis on prognosis of adults patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: a retrospective analysis.38963448 · Zheng, Jing, Zhao, Yanmin, Luo, Yi et al.2024 · 4 citationsAnnals of hematology. 2024;103(8):2983-2991
Risk factors and long-term outcomes for human herpesvirus 6 encephalitis in the early period after allogeneic stem cell transplantation.38937612 · Yu, Yi, Chen, Weihao, Fu, Huarui et al.2024 · 7 citationsBone marrow transplantation. 2024;59(10):1387-1393
Reduced intensity conditioning regimen of fludarabine, busulfan, ATG based haploidentical stem cell transplantation for older or unfit patients.38829409 · Pan, Mingyue, Wu, Yibo, Yang, Luxin et al.2025 · 2 citationsAnnals of hematology. 2024;103(8):3105-3119
Post-transplant de novo anti-HLA donor specific antibodies may contribute to poor graft function after haploidentical haematopoietic stem cell transplantation.38839559 · Ji, Xinyu, Yang, Luxin, Lai, Xiaoyu et al.2024 · 3 citationsHLA. 2024;103(6):e15560
Psychological and physical side effects during G-CSF mobilization in related donors of allo-HCT.38637333 · Cai, Lingxia, Jin, Diange, Lai, Jianbo et al.2024 · 3 citationsAnnals of hematology. 2024;103(8):3199-3206
Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantation.38481248 · Zhu, Panpan, Lai, Xiaoyu, Liu, Lizhen et al.2024 · 3 citationsJournal of translational medicine. 2024;22(1):275
Outcomes of haploidentical peripheral blood stem cell transplantation following myeloablative conditioning using two types of rabbit ATG: a propensity score-matched analysis.38430226 · Shi, Zhuoyue, Gao, Fei, Ding, Dang et al.2024 · 1 citationAnnals of hematology. 2024;103(4):1353-1362
Monocytes in allo-HSCT with aged donors secrete IL-1/IL-6/TNF to increase the risk of GVHD and damage the aged HSCs.38405615 · Li, Xia, Zhang, Wanying, Wang, Yanan et al.2024 · 4 citationsiScience. 2024;27(3):109126
Comparison of long-term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia-positive acute lymphoblastic leukemia: A multicenter retrospective study.38315517 · Guan, Fangshu, Yang, Luxin, Chen, Yi et al.2024 · 8 citationsCancer. 2024;130(12):2139-2149
Selective histone deacetylase inhibitor after allo-HCT for T-cell acute lymphoblastic leukemia or T-cell lymphoma.38263392 · Chen, Weihao, Shi, Jimin, Luo, Yi et al.2024 · 0 citationsBone marrow transplantation. 2024;59(4):561-563
Characteristics of Coronavirus Disease in Allogeneic Hematopoietic Stem Cell Transplantation During the Omicron Wave: A Single-Center Study.38481430 · Zhu, Panpan, Yang, Luxin, Liu, Lizhen et al.2024 · 6 citationsOpen forum infectious diseases. 2024;11(3):ofae038
[Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation in the treatment of secondary acute myeloid leukemia].38527837 · Yuan, X L, Wu, Y B, Song, X L et al.2024 · 3 citationsZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 2024;45(1):41-47
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients With Acute Myeloid Leukemia Harboring KMT2A Rearrangement and Its Prognostic Factors.38270130 · Jiang, Bingqian, Zhao, Yanmin, Luo, Yi et al.2024 · 11 citationsCell transplantation. 2024;33:9636897231225821
Donor-derived Anti-CD19 CAR T cells GC007g for relapsed or refractory B-cell acute lymphoblastic leukemia after allogeneic HSCT: a phase 1 trial.38204488 · Luo, Yi, Gao, Lei, Liu, Jia et al.2024 · 30 citationsEClinicalMedicine. 2024;67:102377
Donor aKIR genes influence the risk of EBV and CMV reactivation after anti-thymocyte globulin-based haploidentical hematopoietic stem cell transplantation.38081622 · Gao, Fei, Shi, Zhuoyue, Shi, Jimin et al.2024 · 3 citationsHLA. 2024;103(1):e15320
Prophylactic versus Preemptive modified donor lymphocyte infusion for high-risk acute leukemia after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study.37907756 · Yang, Luxin, Lai, Xiaoyu, Yang, Ting et al.2024 · 23 citationsBone marrow transplantation. 2024;59(1):85-92
Comparison of the prognostic predictive value of Molecular International Prognostic Scoring System and Revised International Prognostic Scoring System in patients undergoing allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms.37728241 · Yang, Tingting, Jiang, Binqian, Luo, Yi et al.2024 · 5 citationsAmerican journal of hematology. 2023;98(12):E391-E394
Double filtration plasmapheresis combined with rituximab for donor-specific antibody desensitization in haploidentical haematopoietic stem cell transplantation.37621146 · Liu, Lizhen, Ji, Xinyu, Zhu, Panpan et al.2023 · 13 citationsBritish journal of haematology. 2023;203(5):829-839
Survival and late mortality among patients who survived disease-free for 2 years after stem cell transplantation.37306071 · Wu, Linnan, Wu, Yibo, Shi, Jimin et al.2023 · 11 citationsBritish journal of haematology. 2023;202(3):608-622
Haploidentical transplants deliver equal outcomes to matched sibling transplants: a propensity score-matched analysis.37198603 · Wu, Hengwei, Zhao, Yeqian, Gao, Fei et al.2023 · 5 citationsJournal of translational medicine. 2023;21(1):329
Prognostic factors and clinical outcomes in patients with relapsed acute leukemia after allogeneic hematopoietic stem cell transplantation.37120616 · Gao, Yang, Wu, Hengwei, Shi, Zhuoyue et al.2023 · 14 citationsBone marrow transplantation. 2023;58(8):863-873
A novel risk model for predicting early relapse in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem-cell transplantation.37072477 · Yuan, Xiao-Lin, Lai, Xiao-Yu, Wu, Yi-Bo et al.2023 · 7 citationsBone marrow transplantation. 2023;58(7):801-810
[The impact of donor-to-recipient gender compatibility on outcomes of haploid hematopoietic stem cell transplantation in patients with hematological malignancies].36709104 · Hu, S S, Wu, Y B, Zhu, P P et al.2023 · 0 citationsZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 2022;43(12):992-1002
Outcome after allogeneic hematopoietic stem cell transplantation following Venetoclax-based therapy among AML and MDS patients.36318288 · Yang, Ting-Ting, Song, Xiao-Lu, Zhao, Yan-Min et al.2022 · 11 citationsAnnals of hematology. 2022;101(12):2731-2741
Assessment of Patient-Specific Human Leukocyte Antigen Genomic Loss at Relapse After Antithymocyte Globulin-Based T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplant.35385089 · Wu, Hengwei, Shi, Jimin, Luo, Yi et al.2022 · 25 citationsJAMA network open. 2022;5(4):e226114
Impact of Donor-to-Recipient ABO Mismatch on Outcomes of Antithymocyte Globulin-Based Peripheral Blood Stem Cell-Derived Myeloablative Conditioning Haploidentical Stem Cell Transplantation.35231641 · Wu, Yibo, Ni, Lihong, Liu, Yan et al.2023 · 6 citationsTransplantation and cellular therapy. 2022;28(6):331.e1-331.e10
Career total: 196 works. 118 are in this corpus.Showing the 50 most recent.
Profile built from the corpus for this byline.
Author records are still filling in while the Hub is in alpha. If this is your page, you'll be able to claim it soon. Spot a mistake? Tell us.